• Fact Checked
  • February 26, 2026
  • 16 min read

Breast Cancer Risk Factors, Types, and Prevention: Your No-Fear Guide

Table of Contents
  1. 1. What Is Breast Cancer?
  2. 2. Types of Breast Cancer
  3. 3. Recognizing Early Signs
  4. 4. Who Is at Risk?
  5. 5. Emerging and Possible Risk Factors
  6. 6. What Does NOT Increase Your Risk
  7. 7. How Risk Is Assessed
  8. 8. Protective Factors and Ways to Lower Your Risk
  9. 9. When to See a Doctor
  10. 10. Final Thoughts

Key Takeaways

  • 1 in 8 women will develop breast cancer in their lifetime, but when caught early, the 5-year survival rate is 99%. Knowledge and screening are your most powerful tools.
  • Many risk factors are modifiable. Lifestyle choices around alcohol, weight, physical activity, and hormone therapy can meaningfully influence your risk.
  • A lot of things people worry about (think: deodorants, underwire bras, caffeine) don't actually increase breast cancer risk.

Breast cancer touches the lives of millions of women and their families every year. It’s one of the most talked-about and researched cancers, but there are still a lot of misconceptions, particularly around risk factors, that only add to anxiety.

If you’re feeling some of that anxiety right now, know this: Breast cancer research has come a long way. Survival rates are higher than ever. Screening tools are better than ever. And we know more than ever about what actually influences risk, as well as what doesn't. And that’s what we’ve diving into here, with all the science and absolutely no fear-mongering.

This post is for informational purposes only and does not constitute medical advice. See full disclaimer below.

What Is Breast Cancer?

Let’s start with the basics: Breast cancer develops when cells in breast tissue grow abnormally and divide at an uncontrolled rate1. These cells can form a tumor and, if left untreated, may spread to nearby lymph nodes or other parts of the body through a process called metastasis.

Breast cancer is the most common cancer diagnosed in women in the United States, representing about 15% of all new cancer cases2. In 2025, an estimated 316,950 women were diagnosed with invasive breast cancer. Which sounds scary, we know. But here's the number that’s really worth holding onto: when detected at the localized stage (aka caught early), the 5-year survival rate is 99%. Mortality rates have declined by 44% since 1989, and there are now over 4 million breast cancer survivors in the United States. Progress is real, and we know more about breast cancer than ever.

Types of Breast Cancer

Though all breast cancers are, at their core, cells in the breast tissue growing and dividing abnormally, there are different types of breast cancer, with the biggest being invasive vs non-invasive3.

Non-Invasive Breast Cancer

Non-invasive breast cancers remain in their original location and haven't spread to surrounding tissue (aka they haven’t metastasized)4.

Ductal carcinoma in situ (DCIS) is the most common type of non-invasive breast cancer5. It's confined to the breast ducts and is highly treatable when detected early. Lobular carcinoma in situ (LCIS) is a similar condition found in the lobule. It's not technically cancer, but does indicate elevated risk and comes with its own management and follow-up.

Invasive Breast Cancer

Invasive breast cancers are those that have metastasized, spread to the surrounding breast tissue6. Invasive ductal carcinoma is the most common type overall, accounting for 70–80% of cases. Invasive lobular carcinoma accounts for 10–15%.

Less common types

These three types of breast cancers are less common but worth knowing about, since they can look and behave differently from other breast cancers7:

  • Inflammatory breast cancer — Rare but aggressive. Instead of forming a lump, it causes the breast to look red, swollen, and feel warm8. Because it doesn't present like a typical breast cancer, it can be harder to catch early.
  • Triple-negative breast cancer — Lacks the three hormone receptors (estrogen, progesterone, and HER2) that most targeted therapies are designed to treat, which makes it more challenging to treat than other types9.
  • Metastatic breast cancer (Stage 4) — Cancer that has spread beyond the breast to distant organs like the bones, liver, or lungs10. It's not curable, but it is treatable, and many women live with it for years.

Remember, it’s not your job to self-diagnose any kind of cancer, breast cancer or otherwise. Your job is to look for the signs (which we get into next) and make an appointment with your doctor ASAP if you’re ever concerned.

Recognizing Early Signs

Remember that big number we told you to hold onto: a 99% 5-year survival rate when caught early. But what does “caught early” mean, and how can you do it?

Being familiar with your body is one of the most valuable things you can do for your breast health. Signs worth paying attention to include:

  • A new lump in the breast or underarm
  • Changes in breast size or shape
  • Skin changes such as dimpling, puckering, or redness (sometimes described as an orange peel texture)
  • Nipple changes, including inversion or discharge
  • Persistent breast pain localized to one area

None of these symptoms automatically means cancer. Many have benign explanations. But if you notice something new or unusual, schedule an appointment with your healthcare provider. Early detection makes an enormous difference and could potentially save your life.

Who Is at Risk?

Breast cancer risk isn’t determined by any one thing. There is a combination of factors that all contribute11. Some of these risk factors you can control, others you can’t, but no single risk factor means you will definitely be diagnosed. Understanding the complete picture is important, not so you panic, but so you know how to protect your long-term health.

Non-Modifiable Risk Factors

These are the non-modifiable risk factors, meaning those you, unfortunately, cannot control or change:

  • Age. Most breast cancers are diagnosed in women 55 and older. Risk increases gradually with age.
  • Sex. Women are at significantly higher risk than men, though men can and do develop breast cancer.
  • Family history. Having a first-degree relative (mother, sister, daughter) with breast cancer approximately doubles your risk. Having multiple affected relatives increases it further.
  • Genetic mutations. Inherited mutations in the BRCA1 and BRCA2 genes significantly increase lifetime breast cancer risk (up to 72% for BRCA1 carriers). Other genes, including PALB2, CHEK2, ATM, and TP53, also play a role, as do rare hereditary syndromes like Li-Fraumeni syndrome, Cowden syndrome, and Peutz-Jeghers syndrome.
  • Dense breast tissue. Women with dense breasts have more glandular tissue relative to fatty tissue, which is associated with a higher risk. Dense tissue can also make mammograms harder to read.
  • Reproductive history. Starting menstruation before age 12, entering menopause after 55, having a first child after 30, or never having been pregnant are all associated with modestly higher risk, likely due to longer lifetime estrogen exposure. Higher blood estrogen levels more broadly are associated with increased risk.
  • Previous breast conditions. A personal history of atypical ductal hyperplasia, atypical hyperplasia of the breast, or lobular carcinoma in situ increases risk. A personal history of cancer, breast or otherwise, is also relevant.
  • Previous radiation therapy. Women who received radiation therapy to the chest at a young age (often for treatment of another cancer like Hodgkin's lymphoma) have elevated breast cancer risk later in life.

Modifiable risk factors

While you can’t control your age or your genetics, when it comes to risk factors, there are actually a lot of things you can control, including:

  • Alcohol consumption. Drinking alcohol is one of the most consistently documented modifiable risk factors for breast cancer. Even moderate consumption (one drink per day) is associated with a small increase in risk. The relationship appears to be dose-dependent, meaning the more you drink, the greater your risk.
  • Obesity. Obesity after menopause is associated with higher breast cancer risk, largely because fat tissue produces estrogen, and higher estrogen is linked with increased risk of breast cancer. Maintaining a healthy body weight is one of the most meaningful things you can do to reduce your risk.
  • Physical inactivity. Regular physical activity is consistently associated with lower breast cancer risk. Aim for at least 150 minutes of moderate exercise per week.
  • Smoking tobacco. Smoking tobacco has been linked to a modestly increased breast cancer risk, particularly for long-term, heavy smokers who started before their first pregnancy.
  • Hormone replacement therapy (HRT). Hormone replacement therapy, particularly combined HRT (estrogen plus progestin), has been associated with increased breast cancer risk when taken for extended periods. Oestrogen-only HRT carries lower risk. If you're navigating menopause symptoms and are concerned about HRT, it's worth a candid conversation with your provider about your personal risk profile and alternatives.
  • Hormonal birth control. Some studies suggest hormonal birth control, including birth control pills and hormone-releasing IUDs, may be associated with a small increase in risk, though the evidence is mixed and the absolute risk increase is modest for most women.
  • Diet high in saturated fat. A diet high in saturated fat has been associated with higher risk in some studies. Eating more fruits, vegetables, and dairy products and less processed food is associated with better outcomes broadly.
  • Chemical exposures. Exposure to diethylstilbestrol (DES), a synthetic estrogen given to some pregnant women between the 1940s and 1970s, increases risk both for women who took it and their daughters. Emerging research is also looking at bisphenol A (BPA) in plastics and exposure to fine-particle air pollution, though the evidence here is still developing.
  • Low vitamin D levels. Some research suggests that low vitamin D levels may be associated with higher breast cancer risk, though causality hasn't been firmly established.

Emerging and Possible Risk Factors

Science is always evolving, and like we said right at the start, we know more about breast cancer now than ever. But we still don’t know everything. The factors below have come up in research, but none of them have been conclusively proven to cause breast cancer in humans. We're including them because awareness is useful, not because they're established risks on the level of, say, alcohol consumption or BRCA mutations.

  • Chemicals in personal care products. Some research has raised questions about chemicals in cosmetics and sunscreen. The evidence is not conclusive, and none of these have been definitively linked to breast cancer in humans. The FDA and other major health organizations are actively reviewing the research, but haven't found sufficient evidence to issue warnings.
  • Chemicals in hair dyes and straighteners. Exposure to chemicals in hair dyes and straighteners has been flagged in some studies as a potential risk factor, particularly with frequent long-term use. The evidence is still emerging, but it's an area of active research, especially in relation to Black women, who may use these products more frequently.
  • Light exposure at night. Some studies suggest that light exposure at night, particularly for women who work night shifts, may affect melatonin levels in ways that could influence breast cancer risk. The evidence is preliminary but interesting.
  • Radiotherapy. Radiotherapy used to treat other cancers can increase breast cancer risk, particularly when the chest area is involved and treatment occurs at a young age.
  • Atypical hyperplasia. Atypical hyperplasia in the breast, which is a finding sometimes made during biopsy, is associated with elevated risk and warrants closer monitoring.

What Does NOT Increase Your Risk

One of the most useful things we can do is separate real risk factors from the ones that have taken on a life of their own online. Unlike the above risk factors, which are still being researched, the following have been studied extensively and are not supported by scientific evidence as breast cancer risk factors:

  • Antiperspirants and deodorants. Despite persistent rumors, there is no credible evidence linking antiperspirant or deodorant use to breast cancer.
  • Underwire bras. The idea that underwire bras restrict lymph flow and increase risk has no scientific support.
  • Caffeine. No consistent evidence links caffeine consumption to breast cancer risk.
  • Breast implants. Standard breast implants do not increase the risk of the most common forms of breast cancer. (Note: there is a rare type called breast implant-associated anaplastic large cell lymphoma, or BIA-ALCL, which is a different condition.)
  • Mammograms. The radiation exposure from a mammogram is extremely low and does not meaningfully increase cancer risk. The benefits of early detection far outweigh this concern.
  • Cell phones and microwaves. No credible evidence supports a link between cell phone or microwave use and breast cancer.
  • Abortion. Major health organizations, including the American Cancer Society, have concluded that abortion does not increase breast cancer risk.
  • Benign breast disease (non-proliferative). Most benign breast conditions, particularly non-proliferative ones, do not increase risk.
  • Plastic food containers. While BPA is an area of ongoing research, using plastic food containers in normal, everyday ways has not been shown to cause breast cancer.

How Risk Is Assessed

The best way to assess your personal breast cancer risk is not through reading internet articles (no matter how science-backed they are), but in partnership with your doctor.

Official breast cancer risk assessment typically involves a detailed look at your personal and family medical history, including your reproductive history, breast density, prior breast conditions, lifestyle factors, and any known gene mutations. Tools that pull these factors together into a single estimate are called risk calculators or breast cancer risk assessment tools, and again, they are tools best used by a trained medical professional.

The most widely used of these tools is the Tyrer-Cuzick model, which incorporates a broad range of factors including hormonal history, family history of breast cancer, and breast density. The Gail model is another commonly used tool, recommended by the National Cancer Institute and the American Cancer Society for estimating five-year and lifetime risk in women without a strong hereditary component. Your healthcare provider or an oncology specialist can walk you through which tool is most appropriate for your situation.

Genetics and genetic testing

If you have a strong family history of breast or ovarian cancer, are of Ashkenazi Jewish ancestry, or were diagnosed at a young age, genetic testing may be worth discussing with your provider12. Mutations in BRCA1, BRCA2, PALB2, CHEK2, ATM, STK11, and TP53 all carry elevated risk, and knowing your status can meaningfully inform your screening and prevention decisions.

A genetic counselor can help you understand whether testing is appropriate, what the results might mean, and how to act on them, and your primary care doctor can help connect you to that counselor13.

Using your risk assessment

If your risk assessment identifies you as high risk, which is typically defined as a lifetime risk above 20%, your healthcare provider may recommend more frequent breast cancer screening, earlier mammogram initiation, supplemental imaging, genetic testing, or a conversation about breast cancer prevention strategies like chemoprevention14. Women at average or slightly elevated risk still benefit from regular mammography and awareness of their own breast tissue changes (so please don’t ever skip those!).

The goal of risk assessment isn't to create anxiety, but to give you and your providers the information needed to make smarter, more personalized decisions about breast cancer screening and prevention15. White women have slightly higher breast cancer incidence rates, while Black women have higher mortality rates, disparities that make personalized, accessible risk assessment all the more important across all populations.

Protective Factors and Ways to Lower Your Risk

Finding out you have one or more breast cancer risk factors can feel scary—and that reaction is completely understandable16. But having a risk factor is not a diagnosis. It's information. And information, in this case, is genuinely useful, because many of the most significant risk factors have corresponding actions you can take to meaningfully reduce your overall risk. That's what this section is about.

Here are meaningful ways to lower your risk of breast cancer, even with non-modifiable risk factors at play:

  • Maintain a healthy weight. Particularly after menopause, excess body fat produces estrogen that can fuel certain breast cancers. Even modest weight loss can reduce risk.
  • Stay physically active. Regular exercise is one of the most consistently protective factors in the research. Aim for at least 150 minutes of moderate activity per week.
  • Limit alcohol. Even reducing consumption from two drinks per day to one makes a difference.
  • Eat well. A diet rich in fruits and vegetables and low in saturated fats supports overall hormonal health. Some research suggests dairy products may offer modest protective benefits.
  • Breastfeed if possible. Breastfeeding, particularly for longer durations, is associated with a reduced risk of breast cancer, likely due to hormonal and cellular changes during lactation.
  • Be thoughtful about hormone therapy. If you're considering HRT for menopause symptoms, discuss your personal risk profile with your provider. For women navigating menopause who want to avoid hormonal treatments, hormone-free options like Happy V's AM + PM Menopause Relief offer clinically studied support for hot flashes, night sweats, and mood changes without the hormonal risk considerations.*
Happy V Menopause Relief box showcasing clean design and detailed product information.NewSale

Menopause Relief AM + PM

4.8
Rated 4.8 out of 5 stars
79

Supports mood, energy and weight. Minimizes hot flashes and night sweats.

Regular price From $50.99
Regular price $179.97 Sale price From $50.99

 

  • Consider chemoprevention if high-risk. For women at significantly elevated risk, estrogen-blocking medicines like tamoxifen or raloxifene (a strategy called chemoprevention) can substantially reduce risk17. In very high-risk situations, prophylactic mastectomy may be considered. These are conversations to have with a specialist.
  • Get screened. Women with average risk should begin annual mammograms at age 45, or 40 if they choose18. Women with dense breast tissue, a strong family history, or genetic mutations may benefit from additional screening tests like breast MRI. If you have a family history or other risk factors, ask your provider about using a breast cancer risk assessment tool to better understand your personal risk.
  • Do regular breast self-exams. Breast self-exams aren't a substitute for mammograms, but familiarity with your own body means you're more likely to notice changes early19. They are easy to do, take about a minute, and if you have any questions, your gynecologist can show you how.

    When to See a Doctor

    See your healthcare provider promptly if you notice any changes in your breasts, or if you're due for a mammogram and haven't scheduled one. Remember, even women at low risk for breast cancer should get regular mammograms after a certain age.

    If breast cancer runs in your family or you have other risk factors, ask specifically about personalized screening recommendations and whether a risk calculator might be helpful in understanding your situation.

    If you're ever unsure whether something is worth checking out, just go ahead and check it out. Healthcare providers would always rather you come in for something benign than miss something important.

    Final Thoughts

    Breast cancer is common, and that fact is worth sitting with, not to be afraid of, but to take it seriously. The most powerful things you can do are get screened regularly, know your family history, and make lifestyle choices that support your overall health. Most of the rest is noise.

    If You're Looking for Support

    Organizations like the Susan G. Komen Foundation and the American Cancer Society (1-800-227-2345) offer resources and community for women at every stage of this journey. You don't have to navigate it alone.

    Keep the Conversation Going

     

    Disclaimer: This blog is for informational and educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Statements about supplements have not been evaluated by the Food and Drug Administration. For more information about vaginal infections, visit the CDC or speak to a licensed healthcare provider.

    FAQ

    Should I take Happy V® Menopause Relief if I am undergoing cancer treatment?

    Consult your doctor before taking Happy V® Menopause Relief if you are undergoing cancer treatment. 

    How do I take Happy V®’s Menopause Relief?

    Take one (1) AM capsule in the morning with breakfast, and one (1) PM capsule in the evening, about 30 minutes before bedtime. This two-part approach is designed to support your body’s natural circadian rhythm.

    Is Happy V®’s Menopause Relief vegan and allergen-friendly?

    Yes. Our formula is vegan, non-GMO, and free from gluten, soy, dairy, and artificial fillers. Always review the label for ingredient sensitivities.

    [1] Menon G, Alkabban FM, Ferguson T. Breast Cancer. [Updated 2024 Feb 25]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-.

    [2] Henderson JT, Webber EM, Weyrich M, et al. Screening for Breast Cancer: A Comparative Effectiveness Review for the U.S. Preventive Services Task Force [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2024 Apr. (Evidence Synthesis, No. 231.) Chapter 1, Introduction.

    [3] Cleveland Clinic. Breast Cancer: Symptoms, Types, Causes & Treatment. Last updated September 25, 2023. Accessed March 2026.

    [4] Tomlinson-Hansen SE, Khan M, Cassaro S. Breast Ductal Carcinoma in Situ. [Updated 2023 Feb 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-.

    [5] Mayo Clinic Staff. Ductal carcinoma in situ (DCIS): Symptoms & causes. Mayo Clinic. Published March 29, 2024. Accessed March 2026.

    [6] Cleveland Clinic. Invasive Ductal Carcinoma (IDC): Symptoms, Stages & Treatment. Last reviewed July 11, 2024. Accessed March 2026.

    [7] Orrantia-Borunda E, Anchondo-Nuñez P, Acuña-Aguilar LE, et al. Subtypes of Breast Cancer. In: Mayrovitz HN, editor. Breast Cancer [Internet]. Brisbane (AU): Exon Publications; 2022 Aug 6. Chapter 3.

    [8] Cleveland Clinic. Inflammatory Breast Cancer: Symptoms, Causes & Treatment. Last reviewed November 9, 2023. Accessed March 2026.

    [9] Haki M, Bayat R. Innovative Approaches for Molecular Targeted Therapy of Breast Cancer: Interfering with Various Pathway Signaling. Int J Mol Cell Med. 2025;14(1):533-551. doi:10.22088/IJMCM.BUMS.14.1.533

    [10] Cleveland Clinic. Metastatic Breast Cancer: Symptoms, Diagnosis & Treatment. Last reviewed October 18, 2023. Accessed March 2026.

    [11] InformedHealth.org [Internet]. Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2006-. Breast cancer: Learn More – Risk factors for breast cancer. [Updated 2022 Apr 21].

    [12] Andersen MR, Thorpe J, Buist DS, et al. Cancer Risk Awareness and Concern among Women with a Family History of Breast or Ovarian Cancer. Behav Med. 2016;42(1):18-28. doi:10.1080/08964289.2014.947234

    [13] National Society of Genetic Counselors; Genetic Alliance. Making Sense of Your Genes: A Guide to Genetic Counselling. Washington (DC): Genetic Alliance; 2008. Cancer genetic counseling.

    [14] Conley CC, Anderson A, Rodriguez JD, et al. Barriers and facilitators to breast cancer screening among high-risk women: a qualitative study. Breast Cancer Res Treat. 2025;209(1):61-71. doi:10.1007/s10549-024-07471-y

    [15] Xie Z, Wenger N, Stanton AL, et al. Risk estimation, anxiety, and breast cancer worry in women at risk for breast cancer: A single-arm trial of personalized risk communication. Psychooncology. 2019;28(11):2226-2232. doi:10.1002/pon.5211

    [16] Waring AN. Breast cancer: reactions, choices, decisions. Ochsner J. 2000;2(1):40-46.

    [17] Manna EDF, Serrano D, Aurilio G, Bonanni B, Lazzeroni M. Chemoprevention and Lifestyle Modifications for Risk Reduction in Sporadic and Hereditary Breast Cancer. Healthcare (Basel). 2023;11(16):2360. Published 2023 Aug 21. doi:10.3390/healthcare11162360

    [18] Tomlinson-Hansen SE, Budh DP, Sapra A. Breast Cancer Screening in the Average-Risk Patient. [Updated 2024 Oct 3]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-.

    [19] Huang N, Chen L, He J, Nguyen QD. The Efficacy of Clinical Breast Exams and Breast Self-Exams in Detecting Malignancy or Positive Ultrasound Findings. Cureus. 2022;14(2):e22464. Published 2022 Feb 21. doi:10.7759/cureus.22464

    [1] Menon G, Alkabban FM, Ferguson T. Breast Cancer. [Updated 2024 Feb 25]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-.

    [2] Henderson JT, Webber EM, Weyrich M, et al. Screening for Breast Cancer: A Comparative Effectiveness Review for the U.S. Preventive Services Task Force [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2024 Apr. (Evidence Synthesis, No. 231.) Chapter 1, Introduction.

    [3] Cleveland Clinic. Breast Cancer: Symptoms, Types, Causes & Treatment. Last updated September 25, 2023. Accessed March 2026.

    [4] Tomlinson-Hansen SE, Khan M, Cassaro S. Breast Ductal Carcinoma in Situ. [Updated 2023 Feb 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-.

    [5] Mayo Clinic Staff. Ductal carcinoma in situ (DCIS): Symptoms & causes. Mayo Clinic. Published March 29, 2024. Accessed March 2026.

    [6] Cleveland Clinic. Invasive Ductal Carcinoma (IDC): Symptoms, Stages & Treatment. Last reviewed July 11, 2024. Accessed March 2026.

    [7] Orrantia-Borunda E, Anchondo-Nuñez P, Acuña-Aguilar LE, et al. Subtypes of Breast Cancer. In: Mayrovitz HN, editor. Breast Cancer [Internet]. Brisbane (AU): Exon Publications; 2022 Aug 6. Chapter 3.

    [8] Cleveland Clinic. Inflammatory Breast Cancer: Symptoms, Causes & Treatment. Last reviewed November 9, 2023. Accessed March 2026.

    [9] Haki M, Bayat R. Innovative Approaches for Molecular Targeted Therapy of Breast Cancer: Interfering with Various Pathway Signaling. Int J Mol Cell Med. 2025;14(1):533-551. doi:10.22088/IJMCM.BUMS.14.1.533

    [10] Cleveland Clinic. Metastatic Breast Cancer: Symptoms, Diagnosis & Treatment. Last reviewed October 18, 2023. Accessed March 2026.

    [11] InformedHealth.org [Internet]. Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2006-. Breast cancer: Learn More – Risk factors for breast cancer. [Updated 2022 Apr 21].

    [12] Andersen MR, Thorpe J, Buist DS, et al. Cancer Risk Awareness and Concern among Women with a Family History of Breast or Ovarian Cancer. Behav Med. 2016;42(1):18-28. doi:10.1080/08964289.2014.947234

    [13] National Society of Genetic Counselors; Genetic Alliance. Making Sense of Your Genes: A Guide to Genetic Counselling. Washington (DC): Genetic Alliance; 2008. Cancer genetic counseling.

    [14] Conley CC, Anderson A, Rodriguez JD, et al. Barriers and facilitators to breast cancer screening among high-risk women: a qualitative study. Breast Cancer Res Treat. 2025;209(1):61-71. doi:10.1007/s10549-024-07471-y

    [15] Xie Z, Wenger N, Stanton AL, et al. Risk estimation, anxiety, and breast cancer worry in women at risk for breast cancer: A single-arm trial of personalized risk communication. Psychooncology. 2019;28(11):2226-2232. doi:10.1002/pon.5211

    [16] Waring AN. Breast cancer: reactions, choices, decisions. Ochsner J. 2000;2(1):40-46.

    [17] Manna EDF, Serrano D, Aurilio G, Bonanni B, Lazzeroni M. Chemoprevention and Lifestyle Modifications for Risk Reduction in Sporadic and Hereditary Breast Cancer. Healthcare (Basel). 2023;11(16):2360. Published 2023 Aug 21. doi:10.3390/healthcare11162360

    [18] Tomlinson-Hansen SE, Budh DP, Sapra A. Breast Cancer Screening in the Average-Risk Patient. [Updated 2024 Oct 3]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-.

    [19] Huang N, Chen L, He J, Nguyen QD. The Efficacy of Clinical Breast Exams and Breast Self-Exams in Detecting Malignancy or Positive Ultrasound Findings. Cureus. 2022;14(2):e22464. Published 2022 Feb 21. doi:10.7759/cureus.22464